Download the AUA Guidelines-At-A-Glance mobile app:
|Clinically Localized Prostate Cancer||Muscle Invasive Bladder Cancer|
|Renal Mass||Stress Urinary Incontinence (SUI)|
AUA Seeking Review and Comments on the New Draft of the Antimicrobial Prophylaxis Best Practices Statement
The AUA is providing members and other interested parties the opportunity to review and provide comments on the draft Antimicrobial Prophylaxis Best Practices Statement. The draft is available for review immediately. Before being sent a copy of the draft best practices statement, all reviewers must disclose their current industry relationships on the AUA website in order to comply with the AUA's conflict of interest (COI) policy and sign a non-disclosure agreement (NDA) to be provided. Information about the draft must be kept confidential until after the best practices statement has been published to the AUA website in its final state.
Interested reviewers, both AUA members and non-members, should email their name, address, AUA ID #, and email address to LRahimi@auanet.org. Non-members will be required to register for an AUA ID # so they may also disclose their industry relationships on the AUA website and submit a signed copy of the non-disclosure agreement. The deadline to request the guideline is February 19, 2018 in order to qualify to review and receive the draft. Requests after that date cannot be processed.